Case File
efta-01394777DOJ Data Set 10OtherEFTA01394777
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01394777
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
GIOUS140 Lawrence Hirsch
SOF IV — Project Klein
Exclusive deal
Expected Glosing Date:
June 2018
El Fund Secondary
StreGP-led Secondary
K
Single Anet Deal
Seller type:
Alternative funds
Key investment data
Transaction summary
Invested Capital at dose
E60-100m (US$80-120m)
Number of companies
4
Discount to NAV at close
>5%
Strategy
Mid-market buyout
Gross multiple at close
1.1x
Region
Europe / UK
0/0 funded at close
80%
Industries
Business services / Healthcare services
Use of leverage
No
Average age at purchase
9 years
Description
- Motivated quality GP aiming to recapitalize and extend their 2007 mid-
market pan-European fund while providing liquidity to LPs
- Key value driver is largest independent UK premium distributor in its
segment, well positioned to benefit from market tailwinds
- Second largest asset is a network of medical and cosmetics UK clinics
with a private and affluent customer base
- The portfolio also includes an Italian digital marketing company and a
management consulting company with blue chip customers
- Glendower Capital retains discretion on use of follow-on capital
Investment rationale / Glendower Team angle
Glendower Team angle
- Ability to quickly deliver a bespoke solution leveraging Glendower's
track record in complex transactions
- Ability to perform extensive diligence, including onsite visits, full access
to companies' management and industry specialists
- Long 15-year relationship with the GP founder
Investment rationale
- Four well-invested companies positioned to capture growth
opportunities arising from ongoing changes in industry landscape
- Key value driver led by industry veteran with a solid track record
- Value-add potential from recently implemented cost efficiency initiatives
- Opportunity to invest in identified follow-ons at closing, and to contribute
additional capita! to exploit market dislocations
—':or disc-km.5km perposebrgy. The irra:eti-ned ~ed
above I . s.rme
m'rei there is no se-latsida-e Mal
investinent wgi cemmliÅe or rorm part og si Lagra invested Fortie:4m
that blbe, airaibibge pr. arte furthren
due diligence, prove statabe for :3OF
This. slide hauld be [end and meie-wc-d in conjunetion with the important Information and "Important Perfcgmance Inforrnabon' and • Notes to Investment Pedormance sectione.
Glendower
Capital
STRICTLY CONFIDENTIAL
41
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0100819
CONFIDENTIAL
SDNY_GM_00247003
EFTA01394777
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.